Concourse Financial Group Securities, Inc. Vanda Pharmaceuticals Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$4.61 - $6.34 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$3.91 - $6.5 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$3.47 - $4.61 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$3.38 - $4.58 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$4.28 - $6.57 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$4.28 - $6.57 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$5.9 - $6.95 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$6.18 - $7.99 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$6.87 - $10.96 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$9.44 - $11.76 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$9.31 - $11.84 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$10.84 - $16.55 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$15.69 - $21.14 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$15.35 - $21.27 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	BUY	$15.71 - $21.51 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	BUY	$13.42 - $20.28 $0 - $0	0 New	0 $0
Q4 2020 Feb 02, 2021	BUY	$9.77 - $13.81 $0 - $0	0 New	0 $0
Q3 2020 Nov 13, 2020	BUY	$9.32 - $12.02 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$9.66 - $12.02 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	BUY	$7.5 - $16.8 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.38 - $17.47 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$12.27 - $15.79 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	SELL	$13.37 - $18.85 $815 - $1,149	-61 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $1,072 - $1,894	61 New	61 $1,000
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$18.25 - $23.0 $0 - $0	0 New	0 $0

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$40.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$19.8 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$17.9 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$11.6 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$11.2 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $279M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account